Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Use of tumor-informed ctDNA across gastrointestinal cancers.
Authors
Matthew Reilley
Division of Hematology/Oncology, University of Virginia, Charlottesville, VA
Matthew Reilley , Paul Raymond Kunk , Tri Minh Le , Muneeb Rehman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 758)
DOI
10.1200/JCO.2024.42.3_suppl.758
Abstract #
758
Poster Bd #
M13
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Comparative analysis of actionable gene reporting in targeted panels versus comprehensive NGS testing for solid tumor samples.
First Author: Chaugiang Duong
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Development and application of an ultra-sensitive ctDNA mutation profiling assay in monitoring therapy response and drug resistance.
First Author: Tom Zhang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of candidate alterations with primary resistance to KRAS G12D targeting in colorectal cancer.
First Author: Khalid Jazieh
Poster
2023 ASCO Breakthrough
CRISPincette, and detection of low frequency cancer mutations in ctDNA.
First Author: Jin-Soo Kim